Video

Goals for Diabetes Patients to Avoid Readmissions

Conference|ASHP Pharmacy Futures Meeting and Exhibition - American Society of Health System Pharmacists Summer Meeting and Exhibition

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, discusses the types of goals pharmacists should discuss with patients with diabetes in order to avoid readmissions.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, discusses the types of goals pharmacists should discuss with patients with diabetes in order to avoid readmissions.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Related Content
NLA 2025: The Earlier LDL Cholesterol Is Lowered, the Greater the Cardiovascular Risk Reduction
June 1st 2025

NLA 2025: The Earlier LDL Cholesterol Is Lowered, the Greater the Cardiovascular Risk Reduction

Alana Hippensteele, Lead Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
NLA 2025: Practical Strategies for Identifying the Right Patient for Incretin Therapy
June 1st 2025

NLA 2025: Practical Strategies for Identifying the Right Patient for Incretin Therapy

Alana Hippensteele, Lead Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Drawing of the gut microbiome | Image Credit: © ArtemisDiana - stock.adobe.com
May 31st 2025

From Resistance to Response: The Microbiome’s Role in Optimizing Cancer Therapy

Alexandra Gerlach, Associate Editor
NLA 2025: GLP-1 Therapies May Impact Cardiovascular and Renal Health Independent of Weight Loss
May 31st 2025

NLA 2025: GLP-1 Therapies May Impact Cardiovascular and Renal Health Independent of Weight Loss

Alana Hippensteele, Lead Editor